ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Nb Private Equity Partners Limited

Nb Private Equity Partners Limited (NBPU)

21.75
0.50
(2.35%)
Closed July 28 11:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
21.75
Bid
21.00
Ask
22.50
Volume
0.00
0.00 Day's Range 0.00
18.22 52 Week Range 22.50
Market Cap
Previous Close
21.25
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,033
Shares Outstanding
46,237,719
Dividend Yield
-
PE Ratio
36.30
Earnings Per Share (EPS)
0.59
Revenue
89.54M
Net Profit
27.07M

About Nb Private Equity Partners Limited

Sector
Trust,ex Ed,religious,charty
Industry
Trust,ex Ed,religious,charty
Headquarters
Channel Islands, Gbr
Founded
1970
Nb Private Equity Partners Limited is listed in the Trust,ex Ed,religious,charty sector of the London Stock Exchange with ticker NBPU. The last closing price for Nb Private Equity Partners was $21.25. Over the last year, Nb Private Equity Partners shares have traded in a share price range of $ 18.22 to $ 22.50.

Nb Private Equity Partners currently has 46,237,719 shares outstanding. The market capitalization of Nb Private Equity Partners is $982.55 million. Nb Private Equity Partners has a price to earnings ratio (PE ratio) of 36.30.

NBPU Latest News

NBPE Announces June Monthly NAV Estimate & 2H 2024 Dividend Payment

NBPE Announces June Monthly NAV Estimate & 2H 2024 Dividend Payment THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY...

NB Private Equity Partners Limited: Director/PDMR Shareholding

NB Private Equity Partners Limited: Director/PDMR Shareholding NB Private Equity Partners Limited Notification of Transaction by Persons Discharging Managerial Responsibilities (PDMRs) NB Private...

NBPE Announces May Monthly NAV Estimate

NBPE Announces May Monthly NAV Estimate THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR...

NB Private Equity Partners Announces Results of Annual General Meeting

NB Private Equity Partners Announces Results of Annual General Meeting 12 June 2024 NB Private Equity Partners Limited (the “Company”) is pleased to announce that at the Annual General Meeting of...

NBPE Announces April Monthly NAV Estimate

NBPE Announces April Monthly NAV Estimate THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES...

NBPE Publishes Notice of AGM

NBPE Publishes Notice of AGM THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY...

NBPE Announces Audited 2023 Results and 31 March 2024 Est. NAV

NBPE Announces Audited 2023 Results and 31 March 2024 Est. NAV THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN...

NBPE Announces February Monthly NAV Estimate

NBPE Announces February Monthly NAV Estimate THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED...

NB Private Equity Partners Limited: Director/PDMR Shareholding

NB Private Equity Partners Limited: Director/PDMR Shareholding NB Private Equity Partners Limited Notification of Transaction by Persons Discharging Managerial Responsibilities (PDMRs) NB Private...

NB Private Equity Partners Limited: Total Voting Rights

NB Private Equity Partners Limited: Total Voting Rights THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.251.1627906976721.522.521.25123221.86576705DE
40.251.1627906976721.522.521252621.28146853DE
12-0.25-1.136363636362222.520103321.2524495DE
260.753.571428571432122.519.48125520.82292981DE
521.9910.070850202419.7622.518.22103320.60357203DE
1561.055.0724637681220.726.515.5168819.31070797DE
2607.957.039711191313.8526.56.6358815.89796545DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WINTWindtree Therapeutics Inc
$ 8.24
(150.46%)
48.57M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NBSTWNewbury Street Acquisition Corporation
$ 0.1349
(92.71%)
122.1k
YIBOPlanet Image International Ltd
$ 2.915
(53.43%)
260.07k
CREVCarbon Revolution Public Ltd
$ 9.00
(45.87%)
8.06M
NMHINatures Miracle Holding Inc
$ 0.2035
(-48.06%)
7.69M
TANHTantech Holdings Ltd
$ 0.2585
(-47.23%)
6.75M
DXCMDexCom Inc
$ 64.00
(-40.66%)
53.92M
PSIGPS International Group Ltd
$ 1.42
(-31.40%)
716.26k
POAIPredictive Oncology Inc
$ 1.36
(-27.27%)
6.02M
SLNASelina Hospitality PLC
$ 0.0305
(-18.88%)
408.61M
BFIBurgerFi International Inc
$ 0.4206
(97.37%)
313.59M
NVDANVIDIA Corporation
$ 113.06
(0.69%)
293.33M
SQQQProShares UltraPro Short QQQ
$ 9.10
(-2.88%)
176.49M
SGMOSangamo Therapeutics Inc
$ 0.8612
(28.15%)
123.71M

Discussion

View Full Feed
chipboarder chipboarder 2 minutes ago
And a purchase tomorrow will cost you $0.05….attractiveness for a new investor.

Sure most of us have cost basis higher than $0.05 or $0.10 but that is irrelevant to what happens tomorrow. Lack of current volume and enthusiasm is the problem as you have said so many times.
LQMT
hessmessinc hessmessinc 2 minutes ago
FDA submission? Haven't seen anything about that. EMA? This year? I'll believe it when I see it.
AVXL
Sideem Sideem 2 minutes ago
Excellent!!! Thanks for the great news. :-)
BB
Investor2014 Investor2014 2 minutes ago
I don’t think he is, in the sense that the results are encouraging for a new P3 trial designed to iron out the titration difficulties and with a larger n that includes ethnic diversity.
AVXL
wickw50 wickw50 2 minutes ago
Qrtly after closing on Friday…. eom
AMC
domainmaster domainmaster 3 minutes ago
To think JD Davis was the cleanup hitter just a few games ago.
Doc328 Doc328 3 minutes ago
I can't tell without hearing his words at the presentation (especially whether an explanation for all the missing data was stated. He did not prepare the company slides.
AVXL
Meowza Meowza 4 minutes ago
Vulgarity will get you nowhereLOL says you.
AMRN
mrlazerworks mrlazerworks 4 minutes ago
And you’re still replying.. Huh.. I think Chartman has a question for you.
NSAV
plexrec plexrec 5 minutes ago
"There they"--Both will eat their words !!!!! Losers !!!!
AVXL
jammy32 jammy32 5 minutes ago
LOL. BLOCK
ELTP
Doc328 Doc328 6 minutes ago
Thank you for the link. Yes, as expected, the safety cohort n is any patient receiving one dose (hence 335 pooled). The mITT would be the n on top of slide 11 (and used in the MMRM/LSM analysis), the numbers at 48 weeks for ADAS-Cog (slide 13) are the protocol completers (lots of dropout) and onl
AVXL
sage4 sage4 6 minutes ago
Ok understood the tactic of lowering expectations to avoid disappointment. You seem not have followed what’s been going on EMA and FDA submissions lately. Catch them up!
AVXL
maumar maumar 6 minutes ago
Some of the positive comments, especially about Ocrevus ('We expect that Ocrevus subcut represents an incremental CHF2 billion in sales opportunity and we expect this to be increasingly visible in the coming quarters as we are already starting to see some strong pickup in our very early launch count
HALO
hotrodemon hotrodemon 7 minutes ago
They have the full funding and have been open with all of their communications here lately. This has the markings of a Snow White OTC and then some here. i.m.o
HIRU
kayak_wench kayak_wench 7 minutes ago
You seem to have forgotten that approval is secured is no input from FDA in 30 calendar days. Because of that if no input on 30th day, whether a weekend or holiday, than approval can be assumed.
RDGL
12yearplan 12yearplan 7 minutes ago
Still at 8:56, that helps.
"Global surge in benevolence".
Good music fits.
Some of my best work fo sho ;).
Two year back. 2022 and the rest
there helluva link too.
"ambition idealistic = moral ambition, do it "
If only could recall a decent percent
Investor2014 Investor2014 8 minutes ago
Unfortunately Anavex clinical trial outcome news always raises questions, which is why the price of $AVXL tend to move opposite of WGT expectations.

This time is no different.
AVXL
MrMyers MrMyers 8 minutes ago
GTCH Thank you as always for posting. Please post a link to the 6/18/24 filing. I am clearly not as adept as you in Google searching.
GTCH
3331 3331 8 minutes ago
GetSeriousOK - Thought you surrendered: "you can do so with no more comments from me" - 7/18/24. Another lie?
BIEL
w6w9t8015 w6w9t8015 9 minutes ago
thanks for posting more confirmation
HIRU
highlandernew highlandernew 9 minutes ago
🔴🔴Whistleblower FOUND for CITADEL AMC algo?:

*** Click on images to zoom? (if needed?) ***

https://investorshub.advfn.com/uimage/uploads/2024/7/12/ktnzuAMC_ALGO2.png

https:
AMC
waterchaser waterchaser 9 minutes ago
What shorts?
From OTCM:
Short Interest
1,000

(pls don’t come back with bogus “short volume” data from the click-bait site OTCShortreport).
HIRU

Your Recent History

Delayed Upgrade Clock